microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
- 4 January 2014
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (6) , 1099-1107
Abstract
MicroRNAs constitute a novel class of small, non-coding RNAs that negatively regulate gene expression via translational inhibition or mRNA degradation. Aberrant miRNA expression has been implicated in the initiation, progression, and metastasis of hepatocellular carcinoma (HCC). It is well-documented that miRNAs function as either tumor suppressor genes or oncogenes in the development and progression of HCC. Additionally, substantial evidence suggests that unique miRNA signatures can serve as valuable diagnostic and prognostic biomarkers for HCC. Interestingly, certain subsets of miRNAs have also been identified as potential therapeutic targets for HCC.Keywords
This publication has 89 references indexed in Scilit:
- ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinomaExperimental & Molecular Medicine, 2013
- Enhancing the therapeutic efficacy of adenovirus in combination with biomaterialsBiomaterials, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinomaJournal of Hepatology, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells†Hepatology, 2009
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- The functions of animal microRNAsNature, 2004
- Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinomaHepatology, 1997